Status:
COMPLETED
Melanocortin 4 Receptor Mutations and Obesity-associated Diseases
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
Rhythm Pharmaceuticals, Inc.
Conditions:
Obesity
Eligibility:
All Genders
18-70 years
Brief Summary
Mutations in the melanocortin 4 receptor (MC4R) are the most common form of monogenic obesity, and can explain 2-6% of severe obesity. Studies have shown that mutations in MC4R are associated with in...
Eligibility Criteria
Inclusion
- Age 18-70 years
- Men and women
- BMI \> 30 kg/m\^2
Exclusion
- Uncontrolled type 2 diabetes
- Bariatric surgery
- Use of anti-obesity medication
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT01849705
Start Date
October 1 2012
End Date
February 1 2013
Last Update
May 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nutrition, Exercise and Sports, University of Copenhagen
Frederiksberg, Frederiksberg C, Denmark, 1958